M. Steven Piver

8.3k total citations · 1 hit paper
211 papers, 6.2k citations indexed

About

M. Steven Piver is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, M. Steven Piver has authored 211 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Reproductive Medicine, 69 papers in Obstetrics and Gynecology and 45 papers in Surgery. Recurrent topics in M. Steven Piver's work include Ovarian cancer diagnosis and treatment (98 papers), Endometrial and Cervical Cancer Treatments (62 papers) and BRCA gene mutations in cancer (25 papers). M. Steven Piver is often cited by papers focused on Ovarian cancer diagnosis and treatment (98 papers), Endometrial and Cervical Cancer Treatments (62 papers) and BRCA gene mutations in cancer (25 papers). M. Steven Piver collaborates with scholars based in United States, United Kingdom and Ireland. M. Steven Piver's co-authors include Joseph J. Barlow, Ronald E. Hempling, Yoshiaki Tsukada, Julian P. Smith, Felix N. Rutledge, Trudy R. Baker, Gamal H. Eltabbakh, Shashikant B. Lele, Fernando O. Recio and Leslie E. Blumenson and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

M. Steven Piver

208 papers receiving 5.9k citations

Hit Papers

FIVE CLASSES OF EXTENDED HYSTERECTOMY FOR WOMEN WITH CERV... 1975 2026 1992 2009 1975 200 400 600

Peers

M. Steven Piver
John T. Soper United States
Philip J. DiSaia United States
J. Taylor Wharton United States
U. Beller Israel
John H. Malfetano United States
Harry J. Long United States
Jeffrey D. Seidman United States
Wesley C. Fowler United States
John T. Soper United States
M. Steven Piver
Citations per year, relative to M. Steven Piver M. Steven Piver (= 1×) peers John T. Soper

Countries citing papers authored by M. Steven Piver

Since Specialization
Citations

This map shows the geographic impact of M. Steven Piver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Steven Piver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Steven Piver more than expected).

Fields of papers citing papers by M. Steven Piver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Steven Piver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Steven Piver. The network helps show where M. Steven Piver may publish in the future.

Co-authorship network of co-authors of M. Steven Piver

This figure shows the co-authorship network connecting the top 25 collaborators of M. Steven Piver. A scholar is included among the top collaborators of M. Steven Piver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Steven Piver. M. Steven Piver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werness, Bruce A., Susan J. Ramus, Richard A. DiCioccio, et al.. (2003). Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry. International Journal of Gynecological Pathology. 23(1). 29–34. 56 indexed citations
2.
Werness, Bruce A., Susan J. Ramus, Alice S. Whittemore, et al.. (2000). Primary Ovarian Dysgerminoma in a Patient with a Germline BRCA1 Mutation. International Journal of Gynecological Pathology. 19(4). 390–394. 10 indexed citations
3.
Piver, M. Steven, Yoshiaki Tsukada, Bruce A. Werness, et al.. (2000). Comparative Study of Ovarian Cancer Histopathology by Registry Pathologists and Referral Pathologists: A Study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecologic Oncology. 78(2). 166–170. 21 indexed citations
4.
Silver, David F. & M. Steven Piver. (1999). Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect. Gynecologic Oncology. 73(2). 280–284. 69 indexed citations
5.
Eltabbakh, Gamal H., M. Steven Piver, Ronald E. Hempling, & Kyu H. Shin. (1997). Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial. International Journal of Radiation Oncology*Biology*Physics. 38(2). 373–380. 123 indexed citations
6.
Eltabbakh, Gamal H., et al.. (1997). Estrogen Replacement Therapy Following Oophorectomy in Women with a Family History of Ovarian Cancer. Gynecologic Oncology. 66(1). 103–107. 10 indexed citations
7.
Recio, Fernando O., M. Steven Piver, Ronald E. Hempling, & Deborah L. Driscoll. (1996). Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer. 78(10). 2157–2163. 82 indexed citations
8.
Piver, M. Steven, Fernando O. Recio, Trudy R. Baker, & Deborah Driscoll. (1994). Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer. Cancer. 73(6). 1693–1698. 22 indexed citations
9.
DiCioccio, Richard A. & M. Steven Piver. (1992). The Genetics of Ovarian Cancer. Cancer Investigation. 10(2). 135–141. 9 indexed citations
10.
Fanning, James, et al.. (1991). Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecologic Oncology. 40(1). 46–47. 31 indexed citations
11.
Piver, M. Steven. (1990). Invasive cervical cancer in the 1990s. Seminars in Surgical Oncology. 6(6). 359–363. 7 indexed citations
13.
Piver, M. Steven, John H. Malfetano, Trudy R. Baker, Shashikant B. Lele, & David L. Marchetti. (1989). Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary report. Gynecologic Oncology. 35(1). 69–72. 18 indexed citations
14.
Piver, M. Steven, et al.. (1988). The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.. Journal of Clinical Oncology. 6(6). 983–989. 129 indexed citations
15.
Piver, M. Steven, et al.. (1988). Serum α1-acid glycoprotein in epithelial ovarian cancer. Gynecologic Oncology. 29(3). 305–308. 9 indexed citations
16.
Piver, M. Steven, Shashikant Lele, David L. Marchetti, & Lawrence J. Emrich. (1988). Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. Journal of Surgical Oncology. 38(4). 233–239. 38 indexed citations
17.
Piver, M. Steven. (1987). Ovarian malignancies : diagnostic and therapeutic advances. Churchill Livingstone eBooks. 8 indexed citations
18.
Piver, M. Steven. (1983). Diagnóstico precoz del cáncer de ovario. 2 indexed citations
19.
Piver, M. Steven, Joseph J. Barlow, & Ramachandra M. Krishnamsetty. (1981). Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. American Journal of Obstetrics and Gynecology. 139(5). 575–578. 77 indexed citations
20.
Piver, M. Steven, Joseph J. Barlow, & Shashikant B. Lele. (1978). Incidence of subclinical metastasis in stage I and II ovarian carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 52(1). 100–4. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026